Lower within-subject variability for insulin detemir was also confirmed in patients with type 2 diabetes in another clamp study (20), although the latter study had the limitation that no replicate experiments with identical doses were conducted, so the results had to be dose-corrected to investigate variability. Here, INS is linked to type 2 diabetes mellitus.